| 英文别名 |
Cyclosporin A;Cyclosporin A (Cyclosporine ,Antibiotic S 7481F1,Ciclosporin A, Ramihyphin A,CsA);Cyclosporin A solution;CYCLOSPORIN A, TOLYPOCLADIUM INFLATUM;Cyclosporine;Cyclosporine A;Atopica;ciclosporin;ciclosporin A;Cipol N;Cyclosporin A from Tolypocladium inflatum;Cyclosporine Resolution Mixture;Neoplanta;Neoral;ol27-400;Optimmune;Restasis;s7481f1;sandimmun;sandimmun neoral;Sandimmun optoral;Cyclosporin;Antibiotic S 7481F1;Ciclosporine;Ciclosporinum;Ciclosporina;Sandimmune;Equoral;Gengraf;Consupren;Ramihyphin A;SangCyA;83HN0GTJ6D;MLS001333756;CSA;S-Neoral;Sang 35;DSSTox_CID_365;Ciclosporinum [INN-Latin];Ciclosporine [INN-French];Ciclosporina [INN-Spanish];DSSTox_RID_75541;Ciclosporin (Ciclo;Cyclospori;1,4,7,10,13,16,19,22,25,28,31-Undecaazacyclotritriacontane, cyclic peptide deriv.;30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropyl)-3,21-dipropan-2-yl-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;Tox21_110667;VEVYE;(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,2;Pulminiq;1c5f;CYCLOSPORINE [VANDF];Cyclokat;OLO-400;Cyclo(((E)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl)-L-2-aminobutyryl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl);Consupren S;Cyclosporine;Ciclosporin;CYCLOSPORIN A [MI];Cyclosporin A, >=98.5% (TLC);MLS000028376;Cyclosporine [USAN];BMT-ABA-SAR-MLE-VAL-MLE-ALA-DAL-MLE-MLE-MVA;Tox21_110667_1;BDBM50022815;C62H111N11O12;Sang-35;NSC290193;PMATZTZNYRCHOR-CGLBZJNRSA-N;ST-603;SBI-0050230.P003;EX-A4110;MFCD00274558;DTXCID00365;NSC 290193;NCGC00164258-03;M01532;(3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33-[(1R,2R,4E)-1-hydroxy-2-methylhex-4-en-1-yl]-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacontane-2,5,8,11,14,17,20,23,26,29,32-undecone;Cyclo(L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl-((3R,4R,6E)-6,7-didehydro-3-hydroxy-N,4-dimethyl-L-2-aminooctanoyl)-L-2-aminobutanoyl-N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methylleucyl);NCGC00164258-01;Papilock;30-Ethyl-33-(1-hydroxy-2-methyl-hex-4-enyl)-6,9,18,24-tetraisobutyl-3,21-diisopropyl-1,4,7,10,12,15,19,25,28-nonamethyl-1,4,7,10,13,16,19,22,25,28,31undecaaza-cyclotritriacontan-2,5,8,11,14,17,20,23,26,29,32-undecaone;Papilock Mini;CsA & IFN.alpha.;NCGC00164258-02;4jjm;Q-200913;CB-01-09 MMX;Arpimune ME;BRD-K03222093-001-01-8;S 7481F1;30-ethyl-33-[(4E)-1-hydroxy-2-methylhex-4-en-1-yl]-1,4,7,10,12,15,19,25,28-nonamethyl-6,9,18,24-tetrakis(2-methylpropy... |
